Imperial College London

This study aimed to test the safety of a new procedure for Type 1 diabetes. Researchers planned to transplant insulin-producing cells into the front part of the eye in six participants who already had vision problems. The main goal was to see if this unusual location was safe and…

This study is testing whether a new oral drug, XBD173, can improve how blood flows in the brain in response to mental activity in people with Alzheimer's disease. About 51 participants with mild to moderate Alzheimer's will take either the drug or a placebo (dummy pill) for 28 da…

This study is testing a new combination treatment for people with advanced, high-grade neuroendocrine tumors (NETs) who have not yet received chemotherapy for their cancer that has spread. Up to 20 participants will receive an initial phase of chemotherapy plus an immunotherapy d…

This study is testing whether it's practical to run a larger trial using digital tools to help older adults adopt healthier habits. It involves 30 people aged 65+ in London who are starting to feel less robust. Participants will use smartwatches and apps for 3-6 months, or receiv…

This study is testing whether sending mailed reminders and providing a patient guide can help more people with liver cirrhosis or chronic hepatitis B attend their regular liver cancer screening appointments. Researchers want to see if this support helps catch cancer at an earlier…

This study aimed to see if a drug called Capivasertib could help prevent breast cancer from coming back. It focused on women with a specific type of breast cancer who had finished their main treatment but had tiny traces of cancer DNA in their blood, which is an early warning sig…

This study aims to gather basic information to help design future research for a serious lung condition called pulmonary arterial hypertension (PAH). Researchers are using PET scans to see how much of an experimental compound, XBD173, reaches and binds to a specific protein in th…